Human APCS/HEL-S-92n/PTX2 ORF/cDNA clone-Lentivirus particle (NM_001639)
Cat. No.: vGMLP002714
Pre-made Human APCS/HEL-S-92n/PTX2 Lentiviral expression plasmid for APCS lentivirus packaging, APCS lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
Serum amyloid P component/APCS/APCS/HEL-S-92n products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
| Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
|---|---|---|---|
| vGMLP002714 | Human APCS Lentivirus particle | Pilot Grade | 1.0E+8TU |
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| Research Grade | 1.0E+8TU | ||
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMLP002714 |
| Gene Name | APCS |
| Accession Number | NM_001639 |
| Gene ID | 325 |
| Species | Human |
| Product Type | Lentivirus particle (overexpression) |
| Insert Length | 672 bp |
| Gene Alias | HEL-S-92n,PTX2,SAP |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGAACAAGCCGCTGCTTTGGATCTCTGTCCTCACCAGCCTCCTGGAAGCCTTTGCTCACACAGACCTCAGTGGGAAGGTGTTTGTATTTCCTAGAGAATCTGTTACTGATCATGTAAACTTGATCACACCGCTGGAGAAGCCTCTACAGAACTTTACCTTGTGTTTTCGAGCCTATAGTGATCTCTCTCGTGCCTACAGCCTCTTCTCCTACAATACCCAAGGCAGGGATAATGAGCTACTAGTTTATAAAGAAAGAGTTGGAGAGTATAGTCTATACATTGGAAGACACAAAGTTACATCCAAAGTTATCGAAAAGTTCCCGGCTCCAGTGCACATCTGTGTGAGCTGGGAGTCCTCATCAGGTATTGCTGAATTTTGGATCAATGGGACACCTTTGGTGAAAAAGGGTCTGCGACAGGGTTACTTTGTAGAAGCTCAGCCCAAGATTGTCCTGGGGCAGGAACAGGATTCCTATGGGGGCAAGTTTGATAGGAGCCAGTCCTTTGTGGGAGAGATTGGGGATTTGTACATGTGGGACTCTGTGCTGCCCCCAGAAAATATCCTGTCTGCCTATCAGGGTACCCCTCTCCCTGCCAATATCCTGGACTGGCAGGCTCTGAACTATGAAATCAGAGGATATGTCATCATCAAACCCTTGGTGTGGGTCTGA |
| ORF Protein Sequence | MNKPLLWISVLTSLLEAFAHTDLSGKVFVFPRESVTDHVNLITPLEKPLQNFTLCFRAYSDLSRAYSLFSYNTQGRDNELLVYKERVGEYSLYIGRHKVTSKVIEKFPAPVHICVSWESSSGIAEFWINGTPLVKKGLRQGYFVEAQPKIVLGQEQDSYGGKFDRSQSFVGEIGDLYMWDSVLPPENILSAYQGTPLPANILDWQALNYEIRGYVIIKPLVWV |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Biosimilar | GMP-Bios-ab-144 | Pre-Made Dezamizumab biosimilar, Whole mAb, Anti-APCS Antibody: Anti-HEL-S-92n/PTX2/SAP therapeutic antibody |
| Target Antibody | GM-Tg-g-T37742-Ab | Anti-SAMP/ APCS/ HEL-S-92n functional antibody |
| Target Antigen | GM-Tg-g-T37742-Ag | APCS protein |
| ORF Viral Vector | pGMLP002714 | Human APCS Lentivirus plasmid |
| ORF Viral Vector | vGMLP002714 | Human APCS Lentivirus particle |
Target information
| Target ID | GM-T37742 |
| Target Name | Serum amyloid P component/APCS |
|
Gene Group Identifier (Target Gene ID in Homo species) |
325 |
| Gene ID |
100053475 (Equus caballus), 101093332 (Felis catus), 20219 (Mus musculus), 29339 (Rattus norvegicus) 325 (Homo sapiens), 514488 (Bos taurus), 719421 (Macaca mulatta) |
| Gene Symbols & Synonyms | APCS,Apcs,Sap,SAP,PTX2,HEL-S-92n |
| Target Alternative Names | 9.5S alpha-1-glycoprotein,APCS,Apcs,HEL-S-92n,PTX2,SAP,Sap,Serum amyloid P component,Serum amyloid P-component |
| Uniprot Accession |
P02743,P12246,P23680,Q3T004
Additional SwissProt Accessions: P12246,P23680,P02743,Q3T004 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Therapeutics Target, INN Index |
| Disease | cancer, Ovary Cancer, Other diseases of intestines (K55-K64) |
| Disease from KEGG | |
| Gene Ensembl | ENSMUSG00000026542, ENSG00000132703, ENSBTAG00000019616, ENSMMUG00000006685 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


